Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial

BMJ

Volumn 312, Issue 7045, 1996, Pages 1508-1511

  Clifford, K ^a   Rai, R ^a   Watson, H ^a   Franks, S ^a   Regan, L ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; GONADORELIN DERIVATIVE; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FETUS OUTCOME; HORMONE INHIBITION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; LUTEAL PHASE; LUTEINIZING HORMONE RELEASE; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; FEMALE; FOLLICULAR PHASE; HUMANS; INFANT, NEWBORN; LUTEAL PHASE; LUTEINIZING HORMONE; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROGESTERONE;

EID: 0030014213     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.312.7045.1508     Document Type: Article

References (28)

1. Stanger JD, Yovich JL. Reduced in-vitro fertilisation of human oocytes from patients with raised basal luteinising hormone levels during the follicular phase. Br J Obstet Gynaecol 1985; 92: 385–393.
2. Howles CM, Macnamee MC, Edwards RG. Follicular development and early luteal function of conception and non-conceptional cycles after human in-vitro fertilisation: endocrine correlates. Hum Reprod 1987; 2: 17–21.
3. Punnonen R, Ashorn R, Vilja P, Heinonen PK, Kujansuu E, Tuohimaa P. Spontaneous luteinizing hormone surge and cleavage of in vitro fertilized embryos. Fertil Steril 1988; 49: 479–482.
4. Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 1988; 297: 1024–6.
5. Hamilton-Fairley D, Kiddy D, Watson H, Sagle M, Franks S. Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome. Hum Reprod 1991; 6: 1095–9.
6. Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinising hormone, infertility and miscarriage. Lancet 1990; 336: 1141–4.
7. Verma S, Monks N, Turner K, Hooper M, Kumar A, Lenton E. Influence of elevated luteinising hormone during the follicular phase on fertility as assessed in a natural cycle IVF programme. Hum Reprod 1991; 6(suppl 1):60.
8. Sagle M, Bishop K, Ridley N, Alexander FM, Michel M, Bonney RC, et al. Recurrent early miscarriage and polycystic ovaries. BMJ 1988; 297: 1027–8.
9. Tulppala M, Stenman UH, Cacciatore B, Ylikorkala O. Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women. Br J Obstet Gynaecol 1993; 100: 348–352.
10. Watson H, Kiddy DS, Hamilton-Fairley D, Scanlon MJ, Barnard C, Collins WP, et al. Hypersecretion of luteinising hormone and ovarian steroids in women with recurrent early miscarriage. Hum Reprod 1993; 8: 829–833.
11. Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 1994; 9: 1328–32.
12. Porter RN, Smith W, Craft IL, Abdulwahid NA, Jacobs HS. Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet 1984; 2: 1284–5.
13. Rutherford AJ, Subak-Sharpe RJ, Dawson KJ, Margara RA, Franks S, Winston RML. Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormone. BMJ 1988; 296: 1765–8.
14. Antoine JM, Salat-Baroux J, Alvarez S, Cornet D, Tibi C, Mandelbaum J, et al. Ovarian stimulation using human menopausal gonadotrophins with or without luteinising hormone releasing hormone analogues in a long protocol for in-vitro fertilisation: a prospective randomised comparison. Hum Reprod 1990; 5: 565–569.
15. Abdalla HI, Ahuja KK, Leonard T, Morris NN, Honour JW, Jacobs HS. Comparative trial of luteinizing hormone-releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception program. Fertil Steril 1990; 53: 473–478.
16. Saunders DM, Lancaster PAL, Pedisich EL. Increased pregnancy failure rates after clomiphene following assisted reproductive technology. Hum Reprod 1992; 7: 1154–8.
17. Homburg R, Levy T, Berkovitz D, Farchi J, Feldberg D, Ashkenazi J, et al. Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome. Fertil Steril 1993; 59: 527–531.
18. Balen AH, Tan SL, MacDougall J, Jacobs HS. Miscarriage rates following in-vitro fertilisation are increased in women with polycystic ovaries and reduced by pituitary desensitisation with buserelin. Hum Reprod 1993; 8: 959–964.
19. Adams J, Franks S, Polson DW, Mason HD, Abdulwahid N, Tucker M, et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotrophin releasing hormone. Lancet 1985; 2: 1375–8.
20. Polson DW, Mason HD, Saldahna BY, Franks S. Ovulation of a single dominant follicle during treatment with low dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1987; 26: 746–748.
21. Regan L. A prospective study of spontaneous abortion. In: BeardRW,SharpF, eds. Early pregnancy loss: mechanisms and treatment. London: Royal College of Obstetricians and Gynaecologists, 1988: 23–27.
22. Regan L, Braude PR, Trembath PL. Influence of past reproductive performance on the risk of spontaneous abortion. BMJ 1989; 299: 541–545.
23. Dekel N, Galiani D, Aberdam E. Regulation of rat oocyte maturation: involvement of protein kinases. In: BavisterBD,CumminsJ,RoldanERS, eds. Proceedings of Serono symposium: fertilisation in mammals. Norwell, Massachusetts: Serono Symposia USA, 1990: 17–24.
24. Homburg R, Jacobs H. Etiology of miscarriage in polycystic ovary syndrome. Fertil Steril 1989; 51: 196.
25. Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotrophin receptors in non-pregnant uterus, human placenta, fetal membranes and decidua. J Clin Endocrinol Metab 1990; 70: 421–430.
26. Stray-Pederson B, Stray-Pederson S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984; 148: 140–146.
27. Liddell HS, Pattison NS, Zanderigo A. Recurrent miscarriage–outcome after supportive care in early pregnancy. Aust N Z J Obstet Gynaecol 1991; 31: 320–322.
28. Clifford K, Rai R, Regan L. Future pregnancy outcome in women with unexplained recurrent miscarriage [Abstract]. Hum Reprod 1995; 10: 19–20.